Full Text (PDF)
Review Article

Clinical Manifestation and Treatment of Cataract: A Systematic Review

Simrat Kaur, Raj Mishra, SP Subashini

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Medical and Health Sciences 9(1):p 23-25, January – June 2022. | DOI: https://doi.org/10.21088/ijmhs.2347.9981.9122.3

How Cite This Article:

na

Timeline

Received : January 01, 2022         Accepted : February 12, 2022          Published : June 30, 2022

Abstract

A cataract is a clouding or opacification of the normally clear lens of the eye or its capsule (surrounding transparent membrane) that obscures the passage of light through the lens to the retina of the eye. This blinding disease can affect infants, adults, and older people, but it predominates the latter group. It can be bilateral and vary in severity. The disease process progresses gradually without affecting daily activities early on, but with time, especially after the fourth or fifth decade, the cataract will eventually mature, making the lens completely opaque to light interfering with routine activities. Cataracts are a significant cause of blindness worldwide. Treatment options include correction with refractive glasses only at earlier stages, and if cataract mature enough to interfere with routine activities, surgery may be advised, which is very fruitful. The WHO/NPCB (National Programme for Control of Blindness) survey has shown that there is a backlog of over 22 million blind eyes (12 million blind people) in India, and 80.1% of these are blind due to cataract. The annual incidence of cataract blindness is about 3.8 million.


References

  • 1.   Merck Manual Professional Version. https://www. merckmanuals.com/professional/eye-disorders/cataract/cataract?query=cataract#. Accessed June 28, 2021.
  • 2.   Cataract. American Optometric Association. https://www.aoa.org/healthy-eyes/eye-andvision-conditions/cataract?sso=y. Accessed June 28, 2021.
  • 3.   American Academy of Ophthalmology. What Are Cataracts? (https://www.aao.org/eye-health/diseases/what-are-cataracts) Accessed 6/4/2020.
  • 4.   American Optometric Association. Cataract. (https://www.aoa.org/patients-and-public/eyeand-vision-problems/glossary-of-eye-and-visionconditions/cataract) Accessed6/4/2020.
  • 5.   National Eye Institute. Cataracts. (https://www.nei. nih.gov/learn-about-eye-health/eye-conditionsand-diseases/cataracts) Accessed 6/4/2020.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

na


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
January 01, 2022 February 12, 2022 June 30, 2022

DOI: https://doi.org/10.21088/ijmhs.2347.9981.9122.3

Keywords

Transparent membraneOpacificationNuclear cataractsCortical cataracts

Article Level Metrics

Last Updated

Tuesday 07 July 2026, 09:37:43 (IST)


747

Accesses

6
309
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received January 01, 2022
Accepted February 12, 2022
Published June 30, 2022

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share